Membership
Advancement to Fellow of SHEA
SHEA Journal Club
SHEA Spotlight
Careers
Education & Training
Online Education Center
Prevention CHKC
Guidance
Compendium
Pocket Guidelines
Pocket Guidelines Digital Subscription
SHEA Guidelines Print Bundle
Resources
Antimicrobial Stewardship
BACTEC Blood Culture Vial Resources
Baxter IV Supply Chain Disruption Resources
High-Consequence Pathogens
SARS-CoV-2 Resources
Advocacy
Advocate Training & Resources
Emerging Legislation & Regulations
Priority Issues
Publications
Compendium
Podcasts
About
Board of Trustees
Committee Chairs
Strategic Plan
Diversity, Equity & Inclusion (DEI)
Guiding Principles for AI Usage
Disclosure Policy
Facebook
LinkedIn
Threads
Instagram
Bluesky
X
News
MySHEA
IDWeek
SHEA Spring
SHEA Foundation
SHEA Research Network
Donate
Join SHEA
Login
April 2023
The Costs of Inappropriate Outpatient Antibiotics
Phase 2 study of a Exeporfinium chloride (XF-73) gel, a novel agent for
S. aureus
nasal carriage reduction
Undisclosed: the role of aminopenicillins for the treatment of enterococcal UTIs despite
in vitro
resistance
Creation of a cumulative antibiogram for rapidly growing nontuberculous mycobacteria
Changing with the times: refining our mitigation strategies and policies as COVID evolves
We use cookies to help improve your experience
Ok
Enable JavaScript to ensure
website accessibility
